Unknown PHASE4 INTERVENTIONAL 1-arm NCT00837343

A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder

An Open Label, Multicenter, Single Arm, 4-Week Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder

Sponsor: First Affiliated Hospital of Jinan University

Conditions Bipolar Disorder

Interventions quetiapine fumarate tablet (Seroquel)

Updated 4 times since 2017 Last updated: Feb 4, 2009 Started: Dec 31, 2008 Primary completion: Oct 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Bipolar Disorder, this trial is ongoing. The trial is conducted by First Affiliated Hospital of Jinan University and has accumulated 4 data snapshots since 2008. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

First Affiliated Hospital of Jinan University
Guangzhou Mental Hospital
Guangzhou mental Hospital Attached to Guangzhou Civil Affairs Bureau
Second Affiliated Hospital of Guangzhou Medical University

Data source: Guangzhou Mental Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China